{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T03:25:55Z","timestamp":1773717955357,"version":"3.50.1"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2011,3,4]],"date-time":"2011-03-04T00:00:00Z","timestamp":1299196800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0017631","type":"journal-article","created":{"date-parts":[[2011,3,4]],"date-time":"2011-03-04T21:54:26Z","timestamp":1299275666000},"page":"e17631","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["Interleukin-6 Induces Gr-1+CD11b+ Myeloid Cells to Suppress CD8+ T Cell-Mediated Liver Injury in Mice"],"prefix":"10.1371","volume":"6","author":[{"given":"Liang","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaozhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peishuang","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lishan","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengdian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,3,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.pathol.1.110304.100230","article-title":"Immunobiology and pathogenesis of viral hepatitis.","volume":"1","author":"LG Guidotti","year":"2006","journal-title":"Annu Rev Pathol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nri1148","article-title":"Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?","volume":"3","author":"M Croft","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.it.2005.06.003","article-title":"Interfacing T-cell effector and regulatory function through CD137 (4-1BB) co-stimulation.","volume":"26","author":"LM Myers","year":"2005","journal-title":"Trends Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1182\/blood-2006-10-043463","article-title":"CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype.","volume":"109","author":"Y Zhu","year":"2007","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm0697-682","article-title":"Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors.","volume":"3","author":"I Melero","year":"1997","journal-title":"Nat Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/ni798","article-title":"In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses.","volume":"3","author":"ES Halstead","year":"2002","journal-title":"Nat Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"7654","DOI":"10.4049\/jimmunol.1000927","article-title":"CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice.","volume":"185","author":"J Wang","year":"2010","journal-title":"J Immunol"},{"key":"ref8","article-title":"Phase II, 2nd Line melanoma\u2014RAND monotherapy.","year":"2011"},{"key":"ref9","article-title":"Targeted therapy for metastatic melanoma: from bench to bedside.","author":"WJ Hwu","year":"2010"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar1917","article-title":"Interleukin-6 and chronic inflammation.","volume":"8","author":"C Gabay","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1084\/jem.187.4.461","article-title":"Interleukin 6 is required for the development of collagen-induced arthritis.","volume":"187","author":"T Alonzi","year":"1998","journal-title":"J Exp Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"8222","DOI":"10.1073\/pnas.95.14.8222","article-title":"Interleukin 6 plays a key role in the development of antigen-induced arthritis.","volume":"95","author":"S Ohshima","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.4049\/jimmunol.164.9.4878","article-title":"IL-6 is required for the development of Th1 cell-mediated murine colitis.","volume":"164","author":"M Yamamoto","year":"2000","journal-title":"J Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.4049\/jimmunol.161.12.6480","article-title":"IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells.","volume":"161","author":"EB Samoilova","year":"1998","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/75068","article-title":"Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.","volume":"6","author":"R Atreya","year":"2000","journal-title":"Nat Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI1368","article-title":"IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.","volume":"101","author":"Z Xing","year":"1998","journal-title":"J Clin Invest"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"7251","DOI":"10.1073\/pnas.84.20.7251","article-title":"Interferon beta 2\/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.","volume":"84","author":"J Gauldie","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/jhep.2003.50268","article-title":"Interleukin 6\/gp130-dependent pathways are protective during chronic liver diseases.","volume":"38","author":"KL Streetz","year":"2003","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1126\/science.274.5291.1379","article-title":"Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice.","volume":"274","author":"DE Cressman","year":"1996","journal-title":"Science"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1053\/jhep.2003.50378","article-title":"Interleukin 6 is important for survival after partial hepatectomy in mice.","volume":"38","author":"A Blindenbacher","year":"2003","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"11281","DOI":"10.1074\/jbc.M208470200","article-title":"Interleukin-6\/glycoprotein 130-dependent pathways are protective during liver regeneration.","volume":"278","author":"T Wuestefeld","year":"2003","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1084\/jem.179.5.1529","article-title":"T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6.","volume":"179","author":"H Mizuhara","year":"1994","journal-title":"J Exp Med"},{"key":"ref23","first-page":"1608","article-title":"Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis.","volume":"23","author":"H Mizuhara","year":"1996","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"26605","DOI":"10.1074\/jbc.M100740200","article-title":"Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL.","volume":"276","author":"K Kovalovich","year":"2001","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.onc.1205016","article-title":"Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-x(L) proteins.","volume":"21","author":"F Hong","year":"2002","journal-title":"Oncogene"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0006-291X(03)00572-2","article-title":"Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease.","volume":"304","author":"Y Masubuchi","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/hep.510310123","article-title":"Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice.","volume":"31","author":"K Kovalovich","year":"2000","journal-title":"Hepatology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1172\/JCI19974","article-title":"Hepatoprotection via the IL-6\/Stat3 pathway.","volume":"112","author":"R Taub","year":"2003","journal-title":"J Clin Invest"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1172\/JCI23640","article-title":"The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.","volume":"115","author":"C Klein","year":"2005","journal-title":"J Clin Invest"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.4049\/jimmunol.172.9.5648","article-title":"IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners.","volume":"172","author":"R Sun","year":"2004","journal-title":"J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system.","volume":"9","author":"DI Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"10019","DOI":"10.1158\/0008-5472.CAN-07-2354","article-title":"Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression.","volume":"67","author":"SK Bunt","year":"2007","journal-title":"Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00262-010-0846-9","article-title":"Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organ.","volume":"59","author":"J Dubrot","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1084\/jem.20091474","article-title":"Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function.","volume":"207","author":"LE Sander","year":"2010","journal-title":"J Exp Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.1140485","article-title":"Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.","volume":"317","author":"WE Naugler","year":"2007","journal-title":"Science"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","article-title":"Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression.","volume":"140","author":"EJ Park","year":"2010","journal-title":"Cell"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1002\/ijc.24281","article-title":"High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B.","volume":"124","author":"VW Wong","year":"2009","journal-title":"Int J Cancer"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.gastro.2008.03.020","article-title":"A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.","volume":"135","author":"B Hoechst","year":"2008","journal-title":"Gastroenterology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI0214184","article-title":"Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors.","volume":"109","author":"RA Wilcox","year":"2002","journal-title":"J Clin Invest"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/hep.21872","article-title":"Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells.","volume":"46","author":"Y Chen","year":"2007","journal-title":"Hepatology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0017631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T19:43:29Z","timestamp":1712259809000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0017631"}},"subtitle":[],"editor":[{"given":"Holger","family":"Eltzschig","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,3,4]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,3,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0017631","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,4]]}}}